A study for a 45 year old woman who takes Humira - from FDA reports


Summary

35,154 females aged 45 (±5) who take the same drug are studied. This is a personalized study for a 45 year old female patient who has Crohns Disease. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Oct, 11, 2017

35,154 females aged 45 (±5) who take Humira are studied.


Number of reports submitted per year:

Humira for a 45-year old woman.

Information of the patient in this study:

  • Age: 45
  • Gender: female
  • Conditions: Crohns Disease
  • Drugs taken:
    • Humira (adalimumab)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • injection site pain
  • fatigue
  • headache
  • nausea
  • pain
  • diarrhea
  • drug ineffective
  • rashes
  • injection site bruising
  • injection site erythema
1 - 6 months:
  • drug ineffective
  • joint pain
  • rashes
  • fever
  • fatigue
  • pain
  • injection site pain
  • headache
  • psoriasis
  • diarrhea
6 - 12 months:
  • drug ineffective
  • joint pain
  • pain
  • fever
  • psoriasis
  • abdominal pain
  • fatigue
  • rashes
  • headache
  • diarrhea
1 - 2 years:
  • joint pain
  • drug ineffective
  • pain
  • psoriasis
  • fever
  • diarrhea
  • abdominal pain
  • rashes
  • injection site pain
  • nausea
2 - 5 years:
  • joint pain
  • pain
  • drug ineffective
  • diarrhea
  • fever
  • psoriasis
  • fatigue
  • headache
  • injection site pain
  • abdominal pain
5 - 10 years:
  • joint pain
  • drug ineffective
  • pain
  • fatigue
  • diarrhea
  • joint swelling
  • abdominal pain
  • fever
  • injection site pain
  • psoriasis
10+ years:
  • drug ineffective
  • injection site pain
  • joint pain
  • stress and anxiety
  • sinusitis
  • joint swelling
  • high blood pressure
  • peripheral swelling
  • rashes
  • gastrointestinal disorder
not specified:
  • injection site pain
  • drug ineffective
  • fatigue
  • joint pain
  • pain
  • headache
  • injection site erythema
  • nausea
  • rashes
  • diarrhea

Top conditions involved for these people *:

  • Psoriasis (4,579 people, 13.03%)
  • Psoriatic Arthropathy (3,672 people, 10.45%)
  • Pain (2,302 people, 6.55%)
  • Ankylosing Spondylitis (1,943 people, 5.53%)
  • Ulcerative Colitis (1,794 people, 5.10%)

Top co-used drugs for these people *:

  • Methotrexate (5,203 people, 14.80%)
  • Folic Acid (2,472 people, 7.03%)
  • Prednisone (2,020 people, 5.75%)
  • Enbrel (1,252 people, 3.56%)
  • Vitamin D (888 people, 2.53%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Humira, Crohns disease

You may be interested in these reviews

More reviews for: Humira, Crohns disease